Brenda provides leadership, operational expertise, and strategic direction for Phase IIIB/IV interventional studies. Brenda has extensive experience in working with diverse clients and stakeholders across multiple therapeutic areas spanning global Phase II-IV studies. Her understanding of the full drug development life cycle and her ability to embrace both complex and ever-changing regulatory requirements and evolving clinical research landscape ensures effective planning, collaboration, and quality execution that align with client’s vision and expectations.
Brenda has over 25 years of industry experience. During her career, Brenda has held several positions and has led teams across more than 10 business units. These experiences, coupled with innovative initiatives and dedicated, strong operational teams, ensure clients are provided a unique, innovative, and cost-efficient operational model tailored specifically to their goals and objectives.
Brenda earned a bachelor’s degree in Business Administration from the University of Mount Olive and has a professional certificate in international business from UCD Michael Smurfit Graduate Business School in Dublin, Ireland.